Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |